BriaCell Therapeutics Corp. (BCTX): Total Assets
$21.65M
As of 2025-07-31
$27.07M
As of 2026-04-30
-20.2%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | $21.65M | +268.7% | 2025-10-16, Balance as of period end |
| 2024-07-31 | $5.87M | -78.4% | 2025-10-16, Balance as of period end |
| 2023-07-31 | $27.16M | -36.2% | 2024-10-29, Balance as of period end |
| 2022-07-31 | $42.58M | -26.6% | 2023-10-25, Balance as of period end |
| 2021-07-31 | $58.04M | n/a | 2022-10-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2025-07-31 | $21.65M | +268.7% |
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | $21.49M | +274.5% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $21.44M | -9.2% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $22.13M | +30.7% |
| Annovis Bio, Inc. (ANVS) | 2025-12-31 | $21.08M | +51.4% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $21.06M | +179.3% |
| Jyong Biotech Ltd. (MENS) | 2025-12-31 | $20.78M | +226.4% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $22.82M | +88.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
Compare BCTX, PHIO, EMMA, MBRX side by side · Screen every company in Pharmaceutical Preparations ↗